4.5 Review

N-acetylglutamate and its changing role through evolution

期刊

BIOCHEMICAL JOURNAL
卷 372, 期 -, 页码 279-290

出版社

PORTLAND PRESS LTD
DOI: 10.1042/BJ20030002

关键词

arginine biosynthesis; urea cycle; carbamylphosphate synthetase I; hyperammonaemia; N-acetylglutamate synthase; ornithine acetyltransferase

资金

  1. NCRR NIH HHS [M01RR13297] Funding Source: Medline
  2. NICHD NIH HHS [HD 40677, HD32652] Funding Source: Medline
  3. NIDDK NIH HHS [DK47870, R01 DK064913] Funding Source: Medline

向作者/读者索取更多资源

N-Acetylglutamate (NAG) fulfils distinct biological roles in lower and higher organisms. In prokaryotes, lower eukaryotes and plants it is the first intermediate in the biosynthesis of arginine, whereas in ureotelic (excreting nitrogen mostly in the form of urea) vertebrates, it is an essential allosteric cofactor for carbamyl phosphate synthetase I (CPSI), the first enzyme of the urea cycle. The pathway that leads from glutamate to arginine in lower organisms employs eight steps, starting with the acetylation of glutamate to form NAG. In these species, NAG can be produced by two enzymic reactions: one catalysed by NAG synthase (NAGS) and the other by ornithine acetyltransferase (OAT). In ureotelic species, NAG is produced exclusively by NAGS. In lower organisms, NAGS is feedback-inhibited by L-arginine, whereas mammalian NAGS activity is significantly enhanced by this amino acid. The NAGS genes of bacteria, fungi and mammals are more diverse than other arginine-biosynthesis and urea-cycle genes. The evolutionary relationship between the distinctly different roles of NAG and its metabolism in lower and higher organisms remains to be determined. In humans, inherited NAGS deficiency is an autosomal recessive disorder causing hyperammonaemia and a phenotype similar to CPSI deficiency. Several mutations have been-recently identified in the NAGS genes of families affected with this disorder.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据